Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Anthera Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completed the treatment period specified in study AN-SLE3321 or were enrolled in study AN-SLE3321 prior to November 30, 2010
You may not be if
Developed a new medical disease or condition that has made the subject unsuitable for this study in the opinion of the Investigator, including interference with written informed consent, study evaluation, completion, and/or procedures
Pregnant or nursing
Any prior administration of a B-cell modulating therapy other than A-623
Received cyclophosphamide, cyclosporine, anti-TNF alpha therapies, transfusion, plasmapheresis or plasma exchange, IV immunoglobulin, or live vaccines according to listed wash-out periods
Clareo Health | A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321
